Food Addiction Clinical Treatment Program

NCT ID: NCT04373343

Last Updated: 2023-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-21

Study Completion Date

2023-09-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this current study is to establish the feasibility of, and preliminary support for, a clinical treatment program utilizing interventions from various empirically supported treatments for obesity-related eating disorders and substance use disorders

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To establish the feasibility of recruiting, enrolling, and treating individuals who meet criteria for FA in a group behavioral intervention for 16 weeks. Data from the current study will be used for the purposes of further exploration of the FACT program in a larger randomized controlled trial. We hypothesize the study will demonstrate the feasibility of evaluating this treatment in future studies

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Food Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Males and females meeting criteria for severe food addiction and interested in completing 16 week pilot treatment
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

16-week Food Addiction Clinical Treatment (FACT) Program

16-week Food Addiction Clinical Treatment (FACT) Program, first session will be 120 mins, all subsequent sessions will be 90 mins. Treatment will be led, at a minimum, by a full licensed psychologist

Group Type OTHER

16-week Food Addiction Clinical Treatment (FACT) Program

Intervention Type BEHAVIORAL

16-week Food Addiction Clinical Treatment (FACT) Program, first session will be 120 mins, all subsequent sessions will be 90 mins. Treatment will be led, at a minimum, by a full licensed psychologist

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

16-week Food Addiction Clinical Treatment (FACT) Program

16-week Food Addiction Clinical Treatment (FACT) Program, first session will be 120 mins, all subsequent sessions will be 90 mins. Treatment will be led, at a minimum, by a full licensed psychologist

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 25
* BMI \>25
* YFAS \> 6/11 (severe range)
* willing to commit to a 16 week group therapy program from 4 - 5:30 pm on Thursdays in Winston-Salem, NC
* English speaking

Exclusion Criteria

* Current participation in professional weight loss program and unwillingness to suspend it for 16 weeks during treatment
* obesity medications with exception of diabetes medication with weight loss benefit (ie metformin),
* current nicotine use or substance use disorder (based on meeting the clinical cutoff for the Alcohol Use Disorders Identification Test and/or Cannabis Use Disorder Identification Test
* history of weight loss surgery,
* current/history of severe mental illness (\> 3 psychiatric hospitalizations since age 18,
* schizoaffective disorder, bipolar disorder, psychotic disorder, or personality disorder),
* current/history of lithium, abilify, saphris, vraylor, clozaril, latuda, zyprexa, seroquel, risperdal, or Geodon,
* current pregnancy or breastfeeding,
* prior diagnosis of anorexia nervosa, diagnosis of bulimia nervosa in the last 5 years,
* high currents rates of restrictive eating disorder symptoms based on the Eating Disorder Diagnosis Scale (EDDS; (i.e., any endorsement of vomiting or laxative/diuretic use to manage weight and endorsement of fasting or excessive exercise more than 2 or 3 times a week)
Minimum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wake Forest University Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shenelle Edwards-Hampton, PhD

Role: PRINCIPAL_INVESTIGATOR

Wake Forest Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wake Forest Health Sciences

Winston-Salem, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00053663

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Online Relapse Prevention Study
NCT04862247 COMPLETED NA
Personalized Treatment
NCT04183894 COMPLETED NA
Eating Disorder Chatbot Optimization
NCT07218302 NOT_YET_RECRUITING PHASE2
Treatment of Binge Eating Disorder
NCT00041743 COMPLETED NA